Diabetes, obesity, and erectile dysfunction

Hedley, 2004, Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002, JAMA, 291, 2847, 10.1001/jama.291.23.2847 Kelly, 2008, Global burden of obesity in 2005 and projections to 2030, Int J Obes (Lond), 32, 1431, 10.1038/ijo.2008.102 Haslam, 2005, Obesity, Lancet, 366, 1197, 10.1016/S0140-6736(05)67483-1 Hu, 2001, Diet, lifestyle, and the risk of type 2 diabetes mellitus in women, N Engl J Med, 345, 790, 10.1056/NEJMoa010492 Franco, 2007, Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease, Arch Intern Med, 167, 1145, 10.1001/archinte.167.11.1145 Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E Austad, 2006, Why women live longer than men: Sex differences in longevity, Gend Med, 3, 79, 10.1016/S1550-8579(06)80198-1 Tamler, 2007, Preface, Endocrinol Metab Clinics North Am, 36, 107, 10.1016/j.ecl.2007.03.015 Lue, 2004, Summary of the recommendations on sexual dysfunctions in men, J Sex Med, 1, 6, 10.1111/j.1743-6109.2004.10104.x Feldman, 1994, Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study, J Urol, 151, 54, 10.1016/S0022-5347(17)34871-1 Derby, 2000, Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk?, Urology, 56, 302, 10.1016/S0090-4295(00)00614-2 Shabsigh, 2005, Health issues of men: Prevalence and correlates of erectile dysfunction, J Urol, 174, 662, 10.1097/01.ju.0000165389.73148.d1 Heidler, 2007, Is the metabolic syndrome an independent risk factor for erectile dysfunction?, J Urol, 177, 651, 10.1016/j.juro.2006.09.043 Nikoobakht, 2005, The relationship between lipid profile and erectile dysfunction [published retraction appears in Int J Impot Res. 2007;19:617], Int J Impot Res, 17, 523, 10.1038/sj.ijir.3901350 Burke, 2007, Diabetes and sexual dysfunction: Results from the Olmsted County study of urinary symptoms and health status among men, J Urol, 177, 1438, 10.1016/j.juro.2006.11.059 Riedner, 2006, Central obesity is an independent predictor of erectile dysfunction in older men, J Urol, 176, 1519, 10.1016/j.juro.2006.06.049 EI-Sakka, 2007, Association of risk factors and medical comorbidities with male sexual dysfunctions, J Sex Med, 4, 1691, 10.1111/j.1743-6109.2006.00342.x He, 2007, Cigarette smoking and erectile dysfunction among Chinese men without clinical vascular disease, Am J Epidemiol, 166, 803, 10.1093/aje/kwm154 Ponholzer, 2005, Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire, Eur Urol, 47, 80, 10.1016/j.eururo.2004.08.017 Barrett-Connor, 2005, Heart disease risk factors predict erectile dysfunction 25 years later (the Rancho Bernardo Study), Am J Cardiol, 96, 3M, 10.1016/j.amjcard.2005.07.012 Saigal, 2006, Predictors and prevalence of erectile dysfunction in a racially diverse population, Arch Intern Med, 166, 207, 10.1001/archinte.166.2.207 Fonseca, 2005, Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: Common pathways and treatments?, Am J Cardiol, 96, 13M, 10.1016/j.amjcard.2005.07.005 Vinik, 1998, Erectile dysfunction in diabetes, Diabetes Rev, 6, 16 Fedele, 1998, Erectile dysfunction in diabetic subjects in Italy, Diabetes Care, 21, 1973, 10.2337/diacare.21.11.1973 Braun, 2000, Epidemiology of erectile dysfunction: Results of the ‘Cologne Male Survey’, Int J Impot Res, 12, 305, 10.1038/sj.ijir.3900622 Bacon, 2002, Association of type and duration of diabetes with erectile dysfunction in a large cohort of men, Diabetes Care, 25, 1458, 10.2337/diacare.25.8.1458 Rhoden, 2005, Glycosylated haemoglobin levels and the severity of erectile function in diabetic men, BJU Int, 95, 615, 10.1111/j.1464-410X.2005.05349.x Klein, 1996, Prevalence of self-reported erectile dysfunction in people with longterm IDDM, Diabetes Care, 19, 135, 10.2337/diacare.19.2.135 Romeo, 2000, Sexual function in men with diabetes type 2: Association with glycemic control, J Urol, 163, 788, 10.1016/S0022-5347(05)67805-6 Bhatt, 2006, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, JAMA, 295, 180, 10.1001/jama.295.2.180 Thompson, 2005, Erectile dysfunction and subsequent cardiovascular disease, JAMA, 294, 2996, 10.1001/jama.294.23.2996 Vlachopoulos, 2005, Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: A prospective angiographic study, Eur Urol, 48, 996, 10.1016/j.eururo.2005.08.002 Borgquist, 2007, Coronary flow velocity reserve reduction is comparable in patients with erectile dysfunction and in patients with impaired fasting glucose or well-regulated diabetes mellitus, Eur J Cardiovasc Prev Rehabil, 14, 258, 10.1097/HJR.0b013e328021072b Borgquist, 2006, Erectile dysfunction in healthy subjects predicts reduced coronary flow velocity reserve, Int J Cardiol, 112, 166, 10.1016/j.ijcard.2005.08.035 Blumentals, 2004, Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study, Int J Impot Res, 16, 350, 10.1038/sj.ijir.3901174 Gazzaruso, 2004, Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncom plicated type 2 diabetic patients, Circulation, 110, 22, 10.1161/01.CIR.0000133278.81226.C9 Gazzaruso, 2006, Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients, Int J Impot Res, 18, 311, 10.1038/sj.ijir.3901403 Gazzaruso, 2008, Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: A potential protective role for statins and 5-phosphodiesterase inhibitors, J Am Coll Cardiol, 51, 2040, 10.1016/j.jacc.2007.10.069 Ma, 2008, Erectile dysfunction predicts coronary heart disease in type 2 diabetes, J Am Coll Cardiol, 51, 2045, 10.1016/j.jacc.2008.02.051 Montorsi, 2003, Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease, Eur Urol, 44, 360, 10.1016/S0302-2838(03)00305-1 Montorsi, 2006, Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient, Eur Urol, 50, 721, 10.1016/j.eururo.2006.07.015 Montorsi, 2003, Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder?, Eur Urol, 44, 352, 10.1016/S0302-2838(03)00307-5 Tamler, 2008, Assessment of endothelial function in the patient with erectile dysfunction: An opportunity for the urologist, Int J Impot Res, 20, 370, 10.1038/ijir.2008.13 Solomon, 2003, Relation of erectile dysfunction to angiographic coronary artery disease, Am J Cardiol, 91, 230, 10.1016/S0002-9149(02)03113-2 Montorsi, 2005, The artery size hypothesis: A macrovascular link between erectile dysfunction and coronary artery disease, Am J Cardiol, 96, 19M, 10.1016/j.amjcard.2005.07.006 Guay, 2007, ED2: Erectile dysfunction = endothelial dysfunction, Endocrinol Metab Clin North Am, 36, 453, 10.1016/j.ecl.2007.03.007 Billups, 2005, Erectile dysfunction is a marker for cardiovascular disease: Results of the minority health institute expert advisory panel, J Sex Med, 2, 40, 10.1111/j.1743-6109.2005.20104_1.x Seftel, 1997, Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS, Urology, 50, 1016, 10.1016/S0090-4295(97)00512-8 Cooke, 2000, The endothelium: A new target for therapy, Vasc Med, 5, 49, 10.1177/1358836X0000500108 Lekakis, 1998, Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects, Am J Cardiol, 81, 1225, 10.1016/S0002-9149(98)00098-8 Higashi, 2001, Effect of obesity on endothelium-dependent, nitric oxidemediated vasodilation in normotensive individuals and patients with essential hypertension, Am J Hypertens, 14, 1038, 10.1016/S0895-7061(01)02191-4 Kaiser, 2004, Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease, J Am Coll Cardiol, 43, 179, 10.1016/j.jacc.2003.07.042 Steinberg, 2000, Type II diabetes abrogates sex differences in endothelial function in premenopausal women, Circulation, 101, 2040, 10.1161/01.CIR.101.17.2040 Steinberg, 2002, Vascular function, insulin resistance and fatty acids, Diabetologia, 45, 623, 10.1007/s00125-002-0800-2 Brook, 2006, Obesity, weight loss, and vascular function, Endocrine, 29, 21, 10.1385/ENDO:29:1:21 Brook, 2001, Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults, Am J Cardiol, 88, 1264, 10.1016/S0002-9149(01)02088-4 Petrie, 1996, Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease, Circulation, 93, 1331, 10.1161/01.CIR.93.7.1331 Kedzierski, 2001, Endothelin system: The double-edged sword in health and disease, Annu Rev Pharmacol Toxicol, 41, 851, 10.1146/annurev.pharmtox.41.1.851 Yanagisawa, 1988, A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels, J Hypertens Suppl, 6, S188, 10.1097/00004872-198812040-00056 Ito, 1993, Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes, J Clin Invest, 92, 398, 10.1172/JCI116579 Ehrenreich, 1990, Endothelins, peptides with potent vasoactive properties, are produced by human macrophages, J Exp Med, 172, 1741, 10.1084/jem.172.6.1741 Böhm, 2007, The importance of endothelin-1 for vascular dysfunction in cardiovascular disease, Cardiovasc Res, 76, 8, 10.1016/j.cardiores.2007.06.004 Segura, 2007, Obesity, essential hypertension and renin-angiotensin system, Public Health Nutr, 10, 1151, 10.1017/S136898000700064X Yamagishi, 2008, Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications, Curr Pharm Des, 25, 2613, 10.2174/138161208786071326 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Juonala, 2007, Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study, Circulation, 116, 1367, 10.1161/CIRCULATIONAHA.107.690016 Ardigo, 2007, ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk, Eur J Clin Invest, 37, 263, 10.1111/j.1365-2362.2007.01781.x Valkonen, 2001, Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine, Lancet, 358, 2127, 10.1016/S0140-6736(01)07184-7 Mittermayer, 2006, Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease, Arterioscler Thromb Vasc Biol, 26, 2536, 10.1161/01.ATV.0000242801.38419.48 Schnabel, 2005, Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the AtheroGene Study, Circ Res, 97, e53, 10.1161/01.RES.0000181286.44222.61 Elesber, 2006, Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis, Eur Heart J, 27, 824, 10.1093/eurheartj/ehi749 Maas, 2005, Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction, Euro Urol, 48, 1004, 10.1016/j.eururo.2005.07.017 Nawawi, 2003, Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin, Atherosclerosis, 169, 283, 10.1016/S0021-9150(03)00193-X Naya, 2007, Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients, Hypertens Res, 30, 541, 10.1291/hypres.30.541 Silvestro, 2005, Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification, Thromb Haemost, 93, 559, 10.1160/TH04-07-0440 Vlachopoulos, 2006, Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease, Eur Heart J, 27, 2640, 10.1093/eurheartj/ehl341 Giugliano, 2004, Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men, J Endocrinol Invest, 27, 665, 10.1007/BF03347500 Kojda, 1999, Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure, Cardiovasc Res, 43, 562, 10.1016/S0008-6363(99)00169-8 Kuzkaya, 2003, Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase, J Biol Chem, 278, 22546, 10.1074/jbc.M302227200 Cooke, 2004, Asymmetrical dimethylarginine: The uber marker?, Circulation, 109, 1813, 10.1161/01.CIR.0000126823.07732.D5 Koppenol, 1992, Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide, Chem Res Toxicol, 5, 834, 10.1021/tx00030a017 Jiaan, 1995, Age-related increase in an advanced glycation end product in penile tissue, World J Urol, 13, 369, 10.1007/BF00191219 Steinberg, 1997, Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation, J Clin Invest, 100, 1230, 10.1172/JCI119636 Lin, 2000, Origins of circulating endothelial cells and endothelial outgrowth from blood, J Clin Invest, 105, 71, 10.1172/JCI8071 Reyes, 2002, Origin of endothelial progenitors in human postnatal bone marrow, J Clin Invest, 109, 337, 10.1172/JCI0214327 Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221 Eguchi, 2007, Endothelial progenitor cells for postnatal vasculogenesis, Clin Exp Nephrol, 11, 18, 10.1007/s10157-006-0448-1 Masuda, 2000, Endothelial progenitor cells for regeneration, Hum Cell, 13, 153 Foresta, 2005, Circulating endothelial progenitor cells in subjects with erectile dysfunction, Int J Impot Res, 17, 288, 10.1038/sj.ijir.3901311 Baumhäkel, 2006, Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease, Eur Heart J, 27, 2184, 10.1093/eurheartj/ehl202 Hill, 2003, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, N Engl J Med, 348, 593, 10.1056/NEJMoa022287 Mutin, 1999, Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells, Blood, 93, 2951, 10.1182/blood.V93.9.2951 Bemelmans, 1994, Erectile dysfunction in diabetic men: The neurological factor revisited, J Urol, 151, 884, 10.1016/S0022-5347(17)35113-3 Bhasin, 2006, Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline [published correction appears in J Clin Endocrinol Metab. 2006;91:2688], J Clin Endocrinol Metab, 91, 1995, 10.1210/jc.2005-2847 Cunningham, 2006, Testosterone replacement therapy for late-onset hypogonadism, Nat Clin Pract Urol, 3, 260, 10.1038/ncpuro0479 Dhindsa, 2004, Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes, J Clin Endocrinol Metab, 89, 5462, 10.1210/jc.2004-0804 Svartberg, 2004, Waist circumference and testosterone levels in community dwelling men. The Tromsø study, Eur J Epidemiol, 19, 657, 10.1023/B:EJEP.0000036809.30558.8f Dunajska, 2004, Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis, Aging Male, 7, 197, 10.1080/13685530400004181 Deslypere, 1985, Fat tissue: A steroid reservoir and site of steroid metabolism, J Clin Endocrinol Metab, 61, 564, 10.1210/jcem-61-3-564 Gennari, 2004, A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: Effects on bone metabolism, J Clin Endocrinol Metab, 89, 2803, 10.1210/jc.2003-031342 Hayes, 2000, Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback, J Clin Endocrinol Metab, 85, 3027, 10.1210/jc.85.9.3027 de Boer, 2005, Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism, Diabetes Obes Metab, 7, 211, 10.1111/j.1463-1326.2004.00397.x Tripathy, 2003, Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: A common defect?, Metab Syndr Relat Disord, 1, 75, 10.1089/154041903321648270 Svartberg, 2004, The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromsø Study, Diabetes Metab, 30, 29, 10.1016/S1262-3636(07)70086-1 Muller, 2005, Endogenous sex hormones and metabolic syndrome in aging men, J Clin Endocrinol Metab, 90, 2618, 10.1210/jc.2004-1158 Kupelian, 2006, Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men, J Clin Endocrinol Metab, 91, 843, 10.1210/jc.2005-1326 Ding, 2006, Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis, JAMA, 295, 1288, 10.1001/jama.295.11.1288 Braga-Basaria, 2006, Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy, Int J Impot Res, 18, 494, 10.1038/sj.ijir.3901471 Basaria, 2006, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy, Cancer, 106, 581, 10.1002/cncr.21642 Swerdlow, 2005, Mortality in patients with Klinefelter syndrome in Britain: A cohort study, J Clin Endocrinol Metab, 90, 6516, 10.1210/jc.2005-1077 Bojesen, 2006, Morbidity in Klinefelter syndrome: A Danish register study based on hospital discharge diagnoses, J Clin Endocrinol Metab, 91, 1254, 10.1210/jc.2005-0697 Pedersen, 2005, Studies on receptors and actions of steroid hormones in adipose tissue, Dan Med Bull, 52, 258 Mårin, 1996, Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: Effects of testosterone, J Clin Endocrinol Metab, 81, 1018, 10.1210/jc.81.3.1018 Mårin, 1995, Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: Effects of androgens, J Clin Endocrinol Metab, 80, 239, 10.1210/jc.80.1.239 Mårin, 1998, Androgens and abdominal obesity, Baillieres Clin Endocrinol Metab, 12, 441, 10.1016/S0950-351X(98)80191-2 Rebuffé-Scrive, 1991, Effect of testosterone on abdominal adipose tissue in men, Int J Obes, 15, 791 Rondinone, 2006, Adipocyte-derived hormones, cytokines, and mediators, Endocrine, 29, 81, 10.1385/ENDO:29:1:81 Murdolo, 2006, The dysregulated adipose tissue: A connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis, Nutr Metab Cardiovasc Dis, 16, S35, 10.1016/j.numecd.2005.10.016 Ibrahim, 2005, Polypharmacy and possible drug-drug interactions among diabetic patients receiving home health care services, Home Health Care Serv Q, 24, 87, 10.1300/J027v24n01_07 Shiri, 2007, Cardiovascular drug use and the incidence of erectile dysfunction, Int J Impot Res, 19, 208, 10.1038/sj.ijir.3901516 Jackson, 2006, The second Princeton consensus on sexual dysfunction and cardiac risk: New guidelines for sexual medicine, J Sex Med, 3, 28, 10.1111/j.1743-6109.2005.00196.x Kostis, 2005, Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference), Am J Cardiol, 96, 85M, 10.1016/j.amjcard.2005.12.018 Smith, 2007, The prevalence of newly diagnosed hyperlipidaemia in men with erectile dysfunction, BJU Int, 100, 357, 10.1111/j.1464-410X.2007.06988.x Lue, 2000, Erectile dysfunction, N Engl J Med, 342, 1802, 10.1056/NEJM200006153422407 Goldstein, 1998, Oral sildenafil in the treatment of erectile dysfunction. [published correction appears in N Engl J Med. 1998;339:59], N Engl J Med, 338, 1397, 10.1056/NEJM199805143382001 Ballard, 1998, Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes, J Urol, 159, 2164, 10.1016/S0022-5347(01)63299-3 Beavo, 1995, Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms, Physiol Rev, 75, 725, 10.1152/physrev.1995.75.4.725 Sommer, 2005, Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors, World J Urol, 23, 385, 10.1007/s00345-005-0021-7 Koskimäki, 2008, Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study, Am J Med, 121, 592, 10.1016/j.amjmed.2008.02.042 Behr-Roussel, 2005, Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis, Eur Urol, 47, 87, 10.1016/j.eururo.2004.09.005 McMahon, 2004, Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil, J Sex Med, 1, 292, 10.1111/j.1743-6109.04042.x McMahon, 2005, Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction, J Sex Med, 2, 415, 10.1111/j.1743-6109.2005.20360.x Foresta, 2005, PDE-5 inhibitor, vardenafil, increases circulating progenitor cells in humans, Int J Impot Res, 17, 377, 10.1038/sj.ijir.3901325 Foresta, 2006, Circulating endothelial progenitor cells and endothelial function after chronic tadalafil treatment in subjects with erectile dysfunction, Int J Impot Res, 18, 484, 10.1038/sj.ijir.3901465 Bocchio, 2008, Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction, Atherosclerosis, 196, 313, 10.1016/j.atherosclerosis.2006.09.035 Aversa, 2007, Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study, Int J Impot Res, 19, 200, 10.1038/sj.ijir.3901513 Rosano, 2005, Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk, Eur Urol, 47, 214, 10.1016/j.eururo.2004.10.002 Aversa, 2007, Chronic sildenafil in men with diabetes and erectile dysfunction, Exp Opin Drug Metab Toxicol, 3, 451, 10.1517/17425255.3.3.451 Aversa, 2008, Chronic administration of sildenafil improves markers of endothelial function in men with type 2 diabetes, Diabet Med, 25, 37, 10.1111/j.1464-5491.2007.02298.x Mårin, 1992, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men, Int J Obes Relat Metab Discord, 16, 991 Esposito, 2004, Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial, JAMA, 291, 2978, 10.1001/jama.291.24.2978 Esposito, 2006, Mediterranean diet improves erectile function in subjects with the metabolic syndrome, Int J Impot Res, 18, 405, 10.1038/sj.ijir.3901447 Horasanli, 2008, Do lifestyle changes work for improving erectile dysfunction?, Asian J Androl, 10, 28, 10.1111/j.1745-7262.2008.00363.x Pierce, 2008, Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults, Hypertension, 52, 72, 10.1161/HYPERTENSIONAHA.108.111427